Okay, let's tackle this question about Clostridium difficile infection risk. The question is asking which antibiotic increases the risk of C. difficile infection. First, I need to recall the core concept here. C. difficile is a bacterium that causes colitis, often after antibiotic use disrupts normal gut flora. So the key is understanding which antibiotics are more likely to do that.

The core concept would be about antibiotics that significantly alter the gut microbiota, allowing C. difficile to proliferate. Broad-spectrum antibiotics are typically the culprits because they kill off both harmful and beneficial bacteria. Clindamycin is a classic example here. I remember that clindamycin is known to be a high-risk antibiotic for C. difficile infections. Other high-risk ones include cephalosporins, fluoroquinolones, and third-generation cephalosporins.

Now, the correct answer is probably clindamycin. Let me check why. Clindamycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. It's effective against anaerobes and gram-positive bacteria, but its broad spectrum leads to gut flora disruption. This creates an environment where C. difficile can overgrow and produce toxins, leading to colitis.

Looking at the options, assuming the options are clindamycin, amoxicillin, metronidazole, and maybe another antibiotic. Wait, metronidazole is actually a treatment for C. difficile, so that's a distractor. Amoxicillin is a penicillin, which is also a risk but maybe not as high as clindamycin. Cephalosporins like ceftriaxone would also be high risk, but if the options include clindamycin, that's the top choice.

For the incorrect options: Amoxicillin is a beta-lactam antibiotic. While it does contribute to C. difficile risk, it's not the highest. Clindamycin is more notorious. Metronidazole is used to treat C. difficile, so using it would decrease the risk. Maybe another option is vancomycin, which is used for C. difficile, so that's a treatment. The third option could be a narrow-spectrum antibiotic like penicillin G, which is less likely to disrupt the gut flora.

The clinical pearl here is that clindamycin is a classic high-risk antibiotic for C. difficile. Students should remember that broad-spectrum antibiotics, especially clindamycin, cephalosporins, and fluoroquinolones, are the main culprits. The key is the disruption of normal gut flora leading to overgrowth of C. difficile.

**Core Concept**
Clostridium difficile infection (CDI) occurs when antibiotic use disrupts the gut microbiota, allowing C. difficile overgrowth and toxin production. Broad-spectrum antibiotics that target anaerobes and gram-positive bacteria are most strongly associated with CDI risk.

**Why the Correct Answer is Right**
Clindamycin (Option C) is a lincomycin-class antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. It is highly effective against anaerobes and gram-positive organisms but causes significant gut flora disruption. This creates a niche for C. difficile spores to germinate and produce toxins A/B, leading to pseud

✓ Correct Answer: A. Ciprofloxacin